세계의 바이러스 여과 시장 규모 : 지역별, 범위 및 예측

Virus Filtration Market Size And Forecast

Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031 , growing at a CAGR of 11.37% from 2024 to 2031. Global Virus Filtration Market Drivers The market drivers for the Virus Filtration Market can be influenced by various factors. These may include: Boosting the Production of Biopharmaceuticals: Efficient viral filtration techniques are necessary to preserve the safety and purity of biologics, which include monoclonal antibodies, vaccines, and therapeutic proteins, due to the growing demand for these products.

Increasing Rate of Chronic Illnesses:

The demand for biopharmaceutical goods has increased because to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has resulted in a greater requirement for viral filtering to preserve the integrity of these medicines.

Tight Regulating Guidelines:

Strict regulations are in place for viral safety in the manufacturing of biopharmaceuticals from regulatory organisations including the FDA and EMA. Advanced viral filtration technologies are required in order to comply with these criteria.

Technological Progress:

High-capacity filters and sophisticated filtration systems are examples of virus filtration innovations that have improved efficiency and dependability, making them more appealing to biopharmaceutical businesses.

Growing R&D Investment:

One important factor driving the market is biopharmaceutical firms' increased expenditure in R&D to create novel and enhanced viral filtration techniques.

Growth of the Biotechnology Industry:

The biotechnology sector is expanding quickly, especially in developing nations, which increases the need for services and goods related to viral filtering.

Pay Attention to Generics and Biosimilars:

The demand for virus filtration technologies is driven by the expanding market for biosimilars and generic biologics, which need strict virus filtration procedures to match the quality of original biologics.

Growing Viral Contamination Incidence:

The use of virus filtration as an essential safety precaution has expanded due to awareness of and worry over viral contamination in biopharmaceutical products.

Acceptance of One-Time Use Technologies:

The market for viral filtration is expanding due to the tendency in biopharmaceutical manufacturing towards single-use systems because of their low cost and lower danger of cross-contamination.

Component Manufacturing Organisations (CMOs) are Growing:

The need for superior virus filtering solutions to satisfy a range of customer demands is fueled by the growing significance of CMOs in the biopharmaceutical production process.

Global Virus Filtration Market Restraints

Several factors can act as restraints or challenges for the Virus Filtration Market. These may include:

High Filtration System Cost:

The cost of virus filtration systems and related consumables makes it difficult for small and medium-sized businesses to afford them. This expensive initial outlay may act as a major deterrent to adoption and admission.

Sophisticated and Tight Regulatory Needs:

The biopharmaceutical sector is heavily regulated, and strict rules for viral filtering are in place to guarantee the safety of the products. It may take a while and be expensive to comply with these rules, which could postpone product development and market launch.

Technology Difficulties:

It is theoretically difficult to create efficient viral filtering systems that can handle different kinds of viruses without lowering the product's quality or production. The development and application of new filtration methods may be slowed down by these complications.

Restricted Skilled Labour:

Systems for filtering viruses require specific knowledge and abilities to operate. The insufficiency of skilled personnel to oversee these intricate systems can impede the expansion of the sector.

Problems with the supply chain:

Equipment and consumables used in viral filtration have a susceptible supply chain. Critical parts and resources may become scarce due to events like pandemics, natural disasters, or unstable geopolitical conditions.

Competitive Environment:

The market for viral filtering is extremely competitive, with well-established companies holding a dominant position. Due to their strong market presence and devoted clientele, these well-established businesses may be tough for newcomers to compete with.

Economic Recessions:

Funding for research and development in the biopharmaceutical industry may be impacted by economic volatility or recession. Decreased funding may result in less money being invested on novel viral filtration techniques and technologies.

Global Virus Filtration Market Segmentation Analysis

The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User, And Geography.

Virus Filtration Market, By Type

• Kits and Reagents
• Services
• Filtration Systems
• Others

Based on Type, the market is segmented into kits and reagents, services, filtration systems, and others. Kits and Reagents accounted for the largest market share in 2021, and is projected to grow at a CAGR of 11.72% during the forecast period. The reagents help identify viruses that may contaminate the cell substrate or other reagents or materials used in the evaluation process. Qiagen and Merck Millipore are two well-known manufacturers of reagents and kits for virus filtration. Blood, plasma, serum, bodily fluids, and any monoclonal antibody and recombinant proteins are used in the production of biopharmaceuticals.

Virus Filtration Market, By Application

• Medical Devices
• Water Purification
• Air Purification
• Biologicals
• Vaccines and Therapeutics
• Blood and Blood Products
• Cellular and Gene Therapy Products
• Others

Based on Application, the market is segmented into medical devices, water purification, air purification, and biologicals. Biologicals accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 12.08% during the forecast period. Biologicals are being used to treat and correct a wide range of medical situations and metabolic dysfunctions. Virus removal methods involve size exclusion, including filtration, adsorption to specific matrices, including chromatography, and partitioning into a different fraction. Filtration methodologies designed for viral removal applications considerably contribute to a reduction of endogenous and adventitious viral contaminants.

Virus Filtration Market, By End-User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies

Based on End-user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Pharmaceutical & Biotechnology Companies accounted for the largest market share in 2020, and is projected to grow at a CAGR of 11.64% during the forecast period. The increasing geriatric population and the rising majority of chronic medical disorders positively impact the market growth. Also, the growing need for potential therapies and vaccines to treat patients in critical conditions using viral filtration in convalescent plasma to minimize inflammatory mediators. The continued advancement of bioprocessing technologies such as disposable devices, perfusion reactors, and chromatographic resins increases the global demand for pharmaceutical & biotechnology companies.

Virus Filtration Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.
• On the basis of regional analysis, the Global Virus filtration Market is classified into North America, Europe, Asia Pacific and Rest of the world, North America accounted for the largest market share in 2021, and is projected to grow at the highest CAGR during the forecast period. The viral filtration industry in North America continued to hold a significant market share in comparison to the other regions. As the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Moreover, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the region contains several well-known firms. Europe was the second-largest market in 2021, and it is projected to grow at a CAGR.

Key Players

• The major players in the Virus Filtration Market are:
• Merck & Co.
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd.
• Pall Corporation
• Charles River Laboratories
• Sartorius AG
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VIRUS FILTRATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL VIRUS FILTRATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL VIRUS FILTRATION MARKET, BY APPLICATION

• 5.1 Medical Devices
• 5.2 Water Purification
• 5.3 Air Purification
• 5.4 Biologicals
  • 5.4.1 Vaccines and Therapeutics
  • 5.4.2 Blood and Blood Products
  • 5.4.3 Cellular and Gene Therapy Products
  • 5.4.4 Others

6 GLOBAL VIRUS FILTRATION MARKET, BY PRODUCT

• 6.1 Kits and Reagents
• 6.2 Filtration Systems
• 6.3 Services
• 6.4 Other Products

7 GLOBAL VIRUS FILTRATION MARKET, BY END USER

• 7.1 Pharmaceutical & Biotechnology Companies
• 7.2 Contract Research Organizations
• 7.3 Academic Research Institutes
• 7.4 Medical Device Companies

8 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
• 8.6 Rest of the World

9 GLOBAL VIRUS FILTRATION MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Merck & Co.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 GE Healthcare
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Thermo Fisher Scientific, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Lonza Group Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Sartorius AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Asahi Kasei Medical Co., Ltd.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Development
• 10.7 WuXi AppTec
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Development
• 10.8 Pall Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Charles River Laboratories
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research